Open AccessExtent and Clinical Consequences of Antibody Formation Against Adalimumab in Patients With Plaque Psoriasis
Author(s) -
L.L.A. Lecluse,
R.J.B. Driessen,
Phyllis I. Spuls,
E.M.G.J. de Jong,
Steven O. Stapel,
Martijn B. A. van Doorn,
Jan D. Bos,
Gertjan Wolbink
Publication year - 2010
Publication title -
archives of dermatology
Language(s) - English
Resource type - Journals
eISSN - 1538-3652
pISSN - 0003-987X
DOI - 10.1001/archdermatol.2009.347
Subject(s) - adalimumab , medicine , psoriasis , titer , psoriasis area and severity index , gastroenterology , dermatology , antibody , immunology , tumor necrosis factor alpha
To investigate the extent antibodies to adalimumab are formed in patients with plaque psoriasis and whether these antibodies have clinical consequences. Also, to examine the relationship between antibodies to adalimumab and adalimumab trough titers.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom